rejoy-heath-logo
    FeaturesPricing
Request a Demo
rejoy-heath-logo
    FeaturesPricing
Request a Demo
rejoy-heath-logo
Company

The AI care team for clinics and hospitals. Scribe, coder, reception, interpretation, clinical answers, and study support in one suite. You stay in charge.

Contact
Click here to
Contact Support
on WhatsApp

600 California St,

San Francisco, CA 94108

hello@rejoyhealth.com
AI care team
RejoyGPTAI ScribeAI CoderAI ReceptionistAI InterpreterAI Study CompanionClinical Decision SupportMedical Search
Resources
ResourcesQuestion BankContestsCommunityBlogSearch SymptomsSearch CalculatorsSearch DrugsSymptom CheckerPricing
Terms and conditions
Privacy policyTerms of Service
Published on September 3, 2026

At-Home Urine Test for Bladder Cancer: What the New Study Found

Now Hiring · Rejoy Health Team

We're hiring AI Trainers. Remote, contract, $75 to $100 +/hr.

Help train and evaluate the models behind Rejoy Health. No medical or technical background needed. If you write clearly in English, Spanish, French, or another language, we want to hear from you. Work remotely, on your own schedule.

View the role

A new at-home urine test for bladder cancer detected more than 90% of cancers in a UK study. Learn how the test works, its benefits and its limitations.

A new at-home urine test for bladder cancer could help doctors identify people who are more likely to have the disease while reducing the number of invasive diagnostic procedures needed across NHS urology services.

Research involving almost 1,000 patients found that the test detected more than nine out of 10 bladder cancer cases. While the test is not currently considered a replacement for standard diagnostic procedures, researchers say it could eventually help healthcare professionals decide which patients need urgent further investigation.

Bladder cancer is a significant health concern in the UK, with thousands of new cases diagnosed every year. Early diagnosis can be important because treatment options and outcomes can depend on the stage and type of cancer.

What is the new bladder cancer urine test?

The test, known as GALEAS Bladder, analyses a urine sample for genetic changes associated with bladder cancer.

Unlike a cystoscopy, which requires a small camera to be passed through the urethra into the bladder, a urine test is non-invasive and can potentially be completed without an appointment for an invasive examination.

Researchers examined urine samples from 964 patients attending seven NHS urology departments. The test looks for hundreds of DNA mutations linked with bladder cancer across multiple genes.

In the study, 71 of 77 people who were ultimately diagnosed with bladder cancer were identified by the test. This represented a detection rate of approximately 92.2% among the cancers included in the analysis.

The findings were published in European Urology Oncology and involved researchers from the University of Birmingham and diagnostics company Nonacus.

Could a urine test replace a cystoscopy?

Not at this stage.

A cystoscopy remains an important part of bladder cancer diagnosis. During the procedure, a healthcare professional uses a thin camera to examine the inside of the bladder and look for abnormalities.

Although cystoscopy can provide information that a urine test cannot, it is an invasive procedure and can be uncomfortable for patients. The large number of people referred for suspected bladder cancer also places considerable demand on NHS urology services.

The researchers believe a urine test could instead be used as a triage tool.

This means the test could potentially help healthcare professionals identify patients who appear to have a higher likelihood of cancer and prioritise them for further investigation.

People with a lower-risk result might potentially be managed differently, depending on future clinical guidance and the patient's individual circumstances.

Why could an at-home urine test be useful?

One of the biggest potential advantages is convenience.

Patients experiencing symptoms that could indicate bladder cancer are often referred through urgent diagnostic pathways. However, many people investigated for symptoms such as blood in the urine do not ultimately have cancer.

A simple urine test could potentially reduce unnecessary invasive procedures while helping clinicians focus resources on patients who are more likely to need immediate investigation.

Researchers estimated that using GALEAS Bladder to help triage patients could result in around 730 fewer urgent cystoscopies for every 1,000 patients compared with sending everyone directly for an urgent cystoscopy.

If similar results were confirmed in wider clinical use, this could have implications for both patients and NHS services.

For patients, fewer invasive procedures could mean less discomfort and anxiety. For healthcare services, reducing unnecessary cystoscopies could potentially free up appointments and clinical resources.

What are the symptoms of bladder cancer?

The most commonly recognised symptom of bladder cancer is blood in the urine, medically known as haematuria.

Blood may make urine appear pink, red or darker than usual. However, it is not always visible, which is why other urinary symptoms can also be important.

Possible bladder cancer symptoms can include:

  • Blood in the urine
  • Pain, burning or stinging when urinating
  • Needing to urinate more frequently
  • A sudden or urgent need to urinate
  • Repeated urinary tract infections
  • Pain in the lower abdomen or back
  • Unexplained tiredness
  • Unintentional weight loss
  • Reduced appetite
  • Bone pain in more advanced cases

These symptoms do not necessarily mean that someone has bladder cancer. Urinary tract infections, kidney stones and other conditions can cause similar problems.

Nevertheless, persistent or unexplained symptoms should be discussed with a healthcare professional.

How accurate is the new urine test?

The reported results are encouraging, but accuracy needs to be considered carefully.

The study found that the test detected 71 out of 77 confirmed bladder cancer cases, giving a reported detection rate of 92.2%.

However, no medical test is perfect. A test can sometimes produce a false positive result, suggesting that cancer may be present when it is not. It can also produce a false negative result, where cancer is present but the test does not detect it.

The study also involved a specific group of patients who were already undergoing assessment through NHS urology services. Results in a general population could therefore be different.

Further research and clinical evaluation will be important before determining exactly how the test should be incorporated into routine bladder cancer diagnosis.

What happens if you have blood in your urine?

Blood in the urine should not automatically be assumed to be cancer. There are many possible causes, including infections and other urinary conditions.

However, visible blood in the urine should be medically assessed, particularly when there is no obvious explanation.

A doctor may ask about your symptoms, medical history and risk factors before arranging tests. Depending on the circumstances, investigations can include urine tests, blood tests, scans or referral to a specialist.

If a healthcare professional recommends a cystoscopy, patients should not assume that a new urine test means the procedure is unnecessary. At present, a promising urine-based test does not replace the need for appropriate medical assessment.

What does this mean for the future of bladder cancer diagnosis?

The development of non-invasive testing could represent an important step towards making cancer diagnosis more convenient and efficient.

The research suggests that genetic information found in urine may help identify people who are more likely to have bladder cancer. If further evidence supports the findings, urine-based testing could potentially become part of future diagnostic pathways.

For now, the key message is that the technology is promising but still needs to be considered within the wider diagnostic process.

Patients should continue to follow advice from their GP, urologist or other healthcare professional rather than relying on an at-home test alone.

Final thoughts

The new at-home urine test for bladder cancer has produced encouraging results, detecting more than 90% of bladder cancers in the study.

Its greatest potential may be as a triage test that helps determine which patients require urgent cystoscopy, rather than as a direct replacement for established diagnostic procedures.

As further research takes place, urine-based genetic testing could potentially make bladder cancer investigations less invasive and help reduce pressure on NHS urology services.

Anyone experiencing blood in their urine or persistent urinary symptoms should seek medical advice. Early investigation can help determine the underlying cause and ensure that appropriate treatment or follow-up is provided.

Medical Disclaimer

This article is for general information only and should not be used as a substitute for professional medical advice, diagnosis or treatment. A urine test cannot determine whether an individual has bladder cancer without appropriate clinical assessment. If you have blood in your urine, persistent urinary symptoms or concerns about bladder cancer, speak with a qualified healthcare professional. In an emergency or if you have severe symptoms, seek urgent medical attention.

Now Hiring · Rejoy Health Team

Speak English, Spanish, or French? Get paid to train AI.

Rejoy Health is looking for AI Trainers to review model responses, write reference answers, and flag replies that are confusing or unhelpful. You will shape how millions of people receive health information, one careful judgement at a time. There is no degree, medical background, or coding experience required. If you can read and write well in English, Spanish, French, or another language, you can do this work. Remote and contract, $75 to $100+/hr, with hours that fit around study, work, or family commitments.

Apply today

Share this post

Explore Related Articles for Deeper Insights

DOJ Expands Beef Price Investigation to Major Retailers Including Walmart and Costco
The U.S. Department of Justice has expanded its investigation into rising beef prices, bringing seve...
View article →
Why Folic Acid Is Being Added to UK Bread Flour in 2026
From December 2026, folic acid will be added to most non-wholemeal wheat flour sold in the UK. The g...
View article →
Mango Recall 2026: Walmart Mangoes Recalled Over Salmonella Risk
Panorama Produce has recalled select Martina-brand mangoes sold at Walmart stores in four states ove...
View article →

To get more personalized answers,
download now

Login
Register